Skip to main content

Table 3 Coverage estimates and confidence intervals by IRS type

From: Retrospective evaluation of the effectiveness of indoor residual spray with pirimiphos‐methyl (Actellic) on malaria transmission in Zambia

Coverage estimate

2014

2015

2016

Operational coverage

IRS

94.7 (93.6–95.9)

94.3 (93.2–95.4)

92.4 (91.4–93.4)

IRS with mSpray

87.0 (83.5–90.5)

95.0 (93.8–96.3)

88.8 (87.4–90.1)

Structures per population

IRS

0.13 (0.11–0.14)

0.17 (0.15–0.18)

0.17 (0.15–0.20)

IRS with mSpray

0.14 (0.11–0.17)

0.19 (0.14–0.23)

0.21 (0.16–0.25)